Rare incidence of congestive heart failure in gastrointestinal stromal tumor and other sarcoma patients receiving imatinib mesylate.
about
NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors.ErbB signaling in cardiac development and disease.A gist of gastrointestinal stromal tumors: A review.Fluid retention associated with imatinib treatment in patients with gastrointestinal stromal tumor: quantitative radiologic assessment and implications for managementImatinib mesylate: past successes and future challenges in the treatment of gastrointestinal stromal tumors.Tyrosine Kinase Inhibitor-Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia.Imatinib attenuates cardiac fibrosis by inhibiting platelet-derived growth factor receptors activation in isoproterenol induced model.Cardio-Oncology: How New Targeted Cancer Therapies and Precision Medicine Can Inform Cardiovascular Discovery.A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology.Genetic Polymorphisms Contribute to the Individual Variations of Imatinib Mesylate Plasma Levels and Adverse Reactions in Chinese GIST Patients.Imatinib-induced decompensated heart failure in an elderly patient with chronic myeloid leukemia: case report and literature review.Soft tissue sarcoma clinical practice guidelines in oncology.Rapidly progressive dyspnea in gastrointestinal stromal tumor (GIST) with imatinib cardiac toxicity.
P2860
Q33921067-50C1A84A-11FD-4642-B728-2430F96EB89BQ34545577-5BA57B10-D518-4C4A-8B83-69E0DBDBBA0BQ34654203-61A38C6E-9F78-4C1F-B095-B44A74606FC8Q35140171-E1B6912E-02DE-4623-9AE9-55D4B0607BEEQ35607790-CDB104F7-0030-4372-9AD4-CF900BC698CFQ36316309-F39CB979-D005-4188-AB7A-E33CC1E11A5FQ36389384-D7CA9F80-F103-4A73-BD79-FD6B7E696D9CQ36891574-4ACEE0E5-7D93-44B6-ABB9-DF2737285FF0Q37052843-B5673DBA-761D-4901-88C0-EAB68D43C5AFQ37729245-AB0BA59A-7A1C-4246-9BD7-CE4484DD8285Q38076114-04EFCC02-4410-40C5-BC14-50089FC88A44Q42542953-82374536-A684-4651-AF08-B02F83B47E1AQ54980314-1D9FAFBA-CB24-45B0-8E4E-F0DFFC189CAC
P2860
Rare incidence of congestive heart failure in gastrointestinal stromal tumor and other sarcoma patients receiving imatinib mesylate.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Rare incidence of congestive h ...... s receiving imatinib mesylate.
@ast
Rare incidence of congestive h ...... s receiving imatinib mesylate.
@en
type
label
Rare incidence of congestive h ...... s receiving imatinib mesylate.
@ast
Rare incidence of congestive h ...... s receiving imatinib mesylate.
@en
prefLabel
Rare incidence of congestive h ...... s receiving imatinib mesylate.
@ast
Rare incidence of congestive h ...... s receiving imatinib mesylate.
@en
P2093
P2860
P356
P1433
P1476
Rare incidence of congestive h ...... s receiving imatinib mesylate.
@en
P2093
Aarif Y Khakoo
Daniel J Lenihan
Dejka M Araujo
Dominic Fan
Jianhu Zhang
Jonathan C Trent
Juan-Carlos Plana
Robert S Benjamin
Shalin S Patel
Shreyaskumar R Patel
P2860
P304
P356
10.1002/CNCR.24683
P407
P577
2010-01-01T00:00:00Z